RFK’s regulatory plans could overburden small manufacturers, says analyst
HHS Secretary nominee RFK will prioritise regulating device safety, but red tape could leave smaller manufacturing companies behind.
Corporate Governance
Dr Oz nominated to lead CMS despite big pharma ties
Trump 2.0 spells uncertainty for US healthcare, says analyst
US maternal care failings due to ‘focus on reactive care’
FDA’s final rule on LDTs causes concern, but timeline looks unsteady
Reeves’ 2024 budget promises life sciences investment
US senators raise Pfizer and Eli Lilly telehealth prescribing concerns
As mpox spreads, ‘national governments have a moral responsibility to help’
